SOT-102
- Generic Name
- SOT-102
Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma
- First Posted Date
- 2022-09-01
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- SOTIO Biotech a.s.
- Target Recruit Count
- 44
- Registration Number
- NCT05525286
- Locations
- 🇺🇸
Washington University School of Medicine in St. Louis, Saint Louis, Missouri, United States
🇧🇪Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven, Belgium
🇪🇸VHIO - Vall d'Hebron Institut d'Oncologia, Barcelona, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath